Active ingredient
Buprenorphine NDC Codes
Buprenorphine is an active ingredient in 48 finished products listed with the FDA, under 6 names.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Brand and generic names
- Buprenorphine, Brixadi, buprenorphine transdermal system, Butrans, Buprenorphine and Naloxone, Sublocade
- Labelers
- Braeburn Inc., INGENUS PHARMACEUTICALS, LLC, Aveva Drug Delivery Systems Inc., Teva Pharmaceuticals USA, Inc., Amneal Pharmaceuticals NY LLC, Rhodes Pharmaceuticals LLC, Knoa Pharma LLC, Alvogen Inc., Indivior Inc., Lannett Company, Inc.
- Strengths
- Buprenorphine 20 ug/h; Buprenorphine 5 ug/h; Buprenorphine 10 ug/h; Buprenorphine 15 ug/h; Buprenorphine 7.5 ug/h; Buprenorphine 2 mg/1; Naloxone .5 mg/1; Buprenorphine 8 mg/1; Naloxone 2 mg/1; Buprenorphine 8 mg/.16mL; Buprenorphine 16 mg/.32mL; Buprenorphine 24 mg/.48mL; Buprenorphine 128 mg/.36mL; Buprenorphine 32 mg/.64mL; Buprenorphine 64 mg/.18mL; Buprenorphine 96 mg/.27mL; Buprenorphine 100 mg/1; Buprenorphine 300 mg/1
- Dosage forms
- Patch, Extended release, Injection, Patch, Tablet, Solution
- Routes
- Transdermal, Subcutaneous, Sublingual
- Drug classes (FDA established)
- Partial Opioid Agonist, Opioid Antagonist
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 58
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|
| Buprenorphine | Buprenorphine 5 ug/h | Patch, Extended releaseTransdermal | INGENUS PHARMACEUTICALS, LLC | 50742-372 | 50742-0372-04 | — |
| Buprenorphine | Buprenorphine 7.5 ug/h | Patch, Extended releaseTransdermal | INGENUS PHARMACEUTICALS, LLC | 50742-373 | 50742-0373-04 | — |
| Buprenorphine | Buprenorphine 10 ug/h | Patch, Extended releaseTransdermal | INGENUS PHARMACEUTICALS, LLC | 50742-374 | 50742-0374-04 | — |
| Buprenorphine | Buprenorphine 15 ug/h | Patch, Extended releaseTransdermal | INGENUS PHARMACEUTICALS, LLC | 50742-375 | 50742-0375-04 | — |
| Buprenorphine | Buprenorphine 20 ug/h | Patch, Extended releaseTransdermal | INGENUS PHARMACEUTICALS, LLC | 50742-376 | 50742-0376-04 | — |
| Buprenorphine | Buprenorphine 5 ug/h | Patch, Extended releaseTransdermal | Aveva Drug Delivery Systems Inc. | 3215-1521 | 03215-1521-04 | — |
| Buprenorphine | Buprenorphine 7.5 ug/h | Patch, Extended releaseTransdermal | Aveva Drug Delivery Systems Inc. | 3215-1522 | 03215-1522-04 | — |
| Buprenorphine | Buprenorphine 10 ug/h | Patch, Extended releaseTransdermal | Aveva Drug Delivery Systems Inc. | 3215-1523 | 03215-1523-04 | — |
| Buprenorphine | Buprenorphine 15 ug/h | Patch, Extended releaseTransdermal | Aveva Drug Delivery Systems Inc. | 3215-1524 | 03215-1524-04 | — |
| Buprenorphine | Buprenorphine 20 ug/h | Patch, Extended releaseTransdermal | Aveva Drug Delivery Systems Inc. | 3215-1525 | 03215-1525-04 | — |
| Brixadibuprenorphine | Buprenorphine 8 mg/.16mL | InjectionSubcutaneous | Braeburn Inc. | 58284-208 | 58284-0208-01 | — |
| Brixadibuprenorphine | Buprenorphine 16 mg/.32mL | InjectionSubcutaneous | Braeburn Inc. | 58284-216 | 58284-0216-01 | — |
| Brixadibuprenorphine | Buprenorphine 24 mg/.48mL | InjectionSubcutaneous | Braeburn Inc. | 58284-224 | 58284-0224-01 | — |
| Brixadibuprenorphine | Buprenorphine 128 mg/.36mL | InjectionSubcutaneous | Braeburn Inc. | 58284-228 | 58284-0228-01 | — |
| Brixadibuprenorphine | Buprenorphine 32 mg/.64mL | InjectionSubcutaneous | Braeburn Inc. | 58284-232 | 58284-0232-01 | — |
| Brixadibuprenorphine | Buprenorphine 64 mg/.18mL | InjectionSubcutaneous | Braeburn Inc. | 58284-264 | 58284-0264-01 | — |
| Brixadibuprenorphine | Buprenorphine 96 mg/.27mL | InjectionSubcutaneous | Braeburn Inc. | 58284-296 | 58284-0296-01 | — |
| buprenorphine transdermal systembuprenorphine | Buprenorphine 5 ug/h | Patch, Extended releaseTransdermal | Alvogen Inc. | 47781-406 | 47781-0406-04 | — |
| buprenorphine transdermal systembuprenorphine | Buprenorphine 10 ug/h | Patch, Extended releaseTransdermal | Alvogen Inc. | 47781-407 | 47781-0407-04 | — |
| buprenorphine transdermal systembuprenorphine | Buprenorphine 20 ug/h | Patch, Extended releaseTransdermal | Alvogen Inc. | 47781-408 | 47781-0408-04 | — |
| buprenorphine transdermal systembuprenorphine | Buprenorphine 15 ug/h | Patch, Extended releaseTransdermal | Alvogen Inc. | 47781-419 | 47781-0419-04 | — |
| buprenorphine transdermal systembuprenorphine | Buprenorphine 20 ug/h | Patch, Extended releaseTransdermal | LTS Therapy Systems, LLC | 58064-408 | 58064-0408-04 | — |
| Buprenorphine | Buprenorphine 7.5 ug/h | Patch, Extended releaseTransdermal | Teva Pharmaceuticals USA, Inc. | 0093-3239 | 00093-3239-40 | — |
| Buprenorphine | Buprenorphine 5 ug/h | Patch, Extended releaseTransdermal | Amneal Pharmaceuticals NY LLC | 69238-1202 | 69238-1202-02 | — |
| Buprenorphine | Buprenorphine 10 ug/h | Patch, Extended releaseTransdermal | Amneal Pharmaceuticals NY LLC | 69238-1203 | 69238-1203-02 | — |
| Buprenorphine | Buprenorphine 15 ug/h | Patch, Extended releaseTransdermal | Amneal Pharmaceuticals NY LLC | 69238-1204 | 69238-1204-02 | — |
| Buprenorphine | Buprenorphine 20 ug/h | Patch, Extended releaseTransdermal | Amneal Pharmaceuticals NY LLC | 69238-1205 | 69238-1205-02 | — |
| Buprenorphine | Buprenorphine 7.5 ug/h | Patch, Extended releaseTransdermal | Amneal Pharmaceuticals NY LLC | 69238-1505 | 69238-1505-02 | — |
| Buprenorphine | Buprenorphine 5 ug/h | Patch, Extended releaseTransdermal | Teva Pharmaceuticals USA, Inc. | 0093-3656 | 00093-3656-40 | — |
| Buprenorphine | Buprenorphine 10 ug/h | Patch, Extended releaseTransdermal | Teva Pharmaceuticals USA, Inc. | 0093-3657 | 00093-3657-40 | — |
| Buprenorphine | Buprenorphine 15 ug/h | Patch, Extended releaseTransdermal | Teva Pharmaceuticals USA, Inc. | 0093-3658 | 00093-3658-40 | — |
| Buprenorphine | Buprenorphine 20 ug/h | Patch, Extended releaseTransdermal | Teva Pharmaceuticals USA, Inc. | 0093-3659 | 00093-3659-40 | — |
| Sublocadebuprenorphine | Buprenorphine 100 mg/1 | SolutionSubcutaneous | Indivior Inc. | 12496-0100 | 12496-0100-01 | — |
| Sublocadebuprenorphine | Buprenorphine 300 mg/1 | SolutionSubcutaneous | Indivior Inc. | 12496-0300 | 12496-0300-01 | — |
| Buprenorphine | Buprenorphine 7.5 ug/h | PatchTransdermal | Rhodes Pharmaceuticals LLC | 42858-353 | 42858-0353-40 | — |
| Buprenorphine | Buprenorphine 10 ug/h | PatchTransdermal | Rhodes Pharmaceuticals LLC | 42858-493 | 42858-0493-40 | — |
| Buprenorphine | Buprenorphine 15 ug/h | PatchTransdermal | Rhodes Pharmaceuticals LLC | 42858-586 | 42858-0586-40 | — |
| Buprenorphine | Buprenorphine 5 ug/h | PatchTransdermal | Rhodes Pharmaceuticals LLC | 42858-750 | 42858-0750-40 | — |
| Buprenorphine | Buprenorphine 20 ug/h | PatchTransdermal | Rhodes Pharmaceuticals LLC | 42858-839 | 42858-0839-40 | — |
| Buprenorphine and Naloxone | Buprenorphine 2 mg/1; Naloxone .5 mg/1 | TabletSublingual | Lannett Company, Inc. | 62175-452 | 62175-0452-32 | — |
| Buprenorphine and Naloxone | Buprenorphine 8 mg/1; Naloxone 2 mg/1 | TabletSublingual | Lannett Company, Inc. | 62175-458 | 62175-0458-32 | — |
| Buprenorphine and Naloxone | Buprenorphine 2 mg/1; Naloxone .5 mg/1 | TabletSublingual | Bryant Ranch Prepack | 71335-1296 | 71335-1296-0171335-1296-02 | — |
| Buprenorphine and Naloxone | Buprenorphine 8 mg/1; Naloxone 2 mg/1 | TabletSublingual | Bryant Ranch Prepack | 71335-1378 | 71335-1378-0071335-1378-0171335-1378-02+7 more | — |
| Butransbuprenorphine | Buprenorphine 5 ug/h | Patch, Extended releaseTransdermal | Knoa Pharma LLC | 59011-750 | 59011-0750-04 | — |
| Butransbuprenorphine | Buprenorphine 10 ug/h | Patch, Extended releaseTransdermal | Knoa Pharma LLC | 59011-751 | 59011-0751-04 | — |
| Butransbuprenorphine | Buprenorphine 20 ug/h | Patch, Extended releaseTransdermal | Knoa Pharma LLC | 59011-752 | 59011-0752-04 | — |
| Butransbuprenorphine | Buprenorphine 7.5 ug/h | Patch, Extended releaseTransdermal | Knoa Pharma LLC | 59011-757 | 59011-0757-04 | — |
| Butransbuprenorphine | Buprenorphine 15 ug/h | Patch, Extended releaseTransdermal | Knoa Pharma LLC | 59011-758 | 59011-0758-04 | — |
Buprenorphine: common questions
- Which drugs contain Buprenorphine?
- Buprenorphine, Brixadi, buprenorphine transdermal system, Butrans, Buprenorphine and Naloxone, Sublocade.
- Is there a J-code for Buprenorphine?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.